ECM
MEDP icon

Endurant Capital Management’s Medpace MEDP Stock Holding History

Endurant Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-63,100
Closed -$2.29M – 80
2017
Q4 		$2.29M Buy
+63,100
New +$2.21M 0.7% 46

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Endurant Capital Management's MEDP Position: Q1 2018 in Review

Endurant Capital Management sold out of Medpace (MEDP) in Q1 2018, closing a stake of 63,100 shares — an estimated $2.29M sold.

Endurant Capital Management first reported a position in MEDP in Q4 2017 and held it in 1 quarter. The position peaked at $2.29M in Q4 2017. 113 funds tracked by Wall St. Rank hold MEDP as of Q1 2018.

  • Endurant Capital Management reported no remaining Medpace position as of Q1 2018 after selling out during the quarter.
  • Endurant Capital Management sold 63,100 Medpace shares in Q1 2018, an estimated $2.29M.
  • Endurant Capital Management first reported a position in Medpace in Q4 2017 and held it in 1 quarter.
  • Endurant Capital Management's Medpace position peaked at $2.29M in Q4 2017.
  • 113 funds tracked by Wall St. Rank held Medpace as of Q1 2018.

Based on Endurant Capital Management's 13F filing for Q1 2018, filed 15 May 2018.